Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress

Part of paid clinical trials in Richmond, Virginia.

Sponsor
OvationLab
Study ID
NCT07579845
Status
Recruiting
Apply to this trial

Conditions

  • Biological Aging
  • Detoxification
  • Inflammation

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Humic and Fulvic Acid Dietary Supplement — DIETARY_SUPPLEMENT
    BioToxin Binder (CellCore Biosciences, Palm Beach Gardens, FL) - Humic and Fulvic Acid Dietary Supplement

Study Details

The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.

Key Dates

Start date
May 5, 2026
Status verified
May 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Humic and Fulvic Acid Dietary Supplement

Primary Outcome Measure

TruDiagnostic - Epigenetic Testing [ Time Frame: Change in TruAge from baseline to 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
OvationLabRichmondVirginia23220
Study Administration
[email protected]
‪(240) 232-2103‬

Find similar trials in Richmond, VA

By research site
OvationLab· Richmond, VA

Related Studies